Create
Log in
Enquire now
VALANX
VALANX is a site-specific protein conjugation platform founded in 2017 by Michael Lukesch.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
Accelerator
RebelBio
AngelList URL
angel.co/valanx-biotech-1
B2X
B2B
Blog
medium.com/@valanxbio
CEO
Michael Lukesch
0
Company Operating Status
Active
Country
Austria
0
Crunchbase URL
crunchbase.com/organiz...-biotech
Facebook URL
@valanxbio
Founded Date
2017
0
Founder
Michael Lukesch
0
Patrik Fladischer
Full Address
Plöcking 1 IST Park Building 3400 Klosterneuburg, Austria
0
Headquarters
Vienna
Accelerator Batch
RebelBio Cohort 4
Industry
Pharmaceutical Biology
Biomedical engineering
Synthetic biology
Biology
Biotechnology
Drug delivery
Engineering
Health technology
Investors
Tecnet Equity
SOSV
Fujifilm
Fondation Fournier-Majoie
XISTA Science Ventures
SkyGene
Urs Spitz
Latest Funding Round Date
March 12, 2026
Latest Funding Round Amount (USD)
3,500,000
Latest Funding Type
Venture round
LinkedIn URL
@company/valanxbiotech
Location
Klosterneuburg
0
Number of Employees (Ranges)
1 – 10
0
Pitchbook URL
pitchbook.com/profiles...180469-81
Total Funding Amount (USD)
5,900,000
Twitter URL
@valanxbio
Official Website
valanx.bio
Wellfound ID
valanx-biotech-1
Find more companies like VALANX
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Pricing
Enterprise
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE